Skip to main content
S&P 5007,591.70-0.58%DOW52,064.10-0.60%NASDAQ26,081.72-0.65%BTC$76,724.00-1.85%ETH$2,451.02-0.51%GOLD$4,361.60-1.04%OIL$103.06+0.57%
Smart Investors Daily
EV

NYSE · EVR

Evercore Inc.

Financial Services · Financial - Capital Markets

$287.92

Down-$4.69 (-1.63%)

Updated Sep 10, 2026, 6:35 PM

SID Score

5.4/10

Composite research score

Smart Money

58/100

Neutral

Market cap
13.3B
P/E ratio
25.24
Dividend yield
1.15%
52-week range
$265.87 – $388.71
Volume
299.14K
Avg. volume
415.44K

Price performance

EVR price history

1M range · 20 trading sessions · Daily adjusted prices

EVR closed at $287.92 after 20 trading sessions, down 4.01% for the selected period.

Last close
$287.92
Period change
-4.01%
Period low
$286.23
Period high
$312.43
Daily close
View OHLC price history
EVR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 9, 2026$293.43$296.56$287.19$287.92299.14K
Sep 8, 2026$296.63$299.40$293.80$295.67405.34K
Sep 4, 2026$294.01$298.41$291.81$297.92332.42K
Sep 3, 2026$292.98$300.24$292.21$296.91416.05K
Sep 2, 2026$286.15$294.65$284.54$288.69551.81K
Sep 1, 2026$281.53$294.08$280.02$286.23571.97K
Aug 31, 2026$287.77$289.985$284.86$286.43607.2K
Aug 28, 2026$291.40$294.55$286.79$290.11356.77K
Aug 27, 2026$291.545$295.37$287.62$292.12405.76K
Aug 26, 2026$289.01$294.04$286.19$291.42493.85K
Aug 25, 2026$291.61$292.341$286.6401$289.54430.98K
Aug 24, 2026$292.00$294.18$287.85$290.11499.6K
Aug 21, 2026$290.37$294.61$289.5075$291.89483.26K
Aug 20, 2026$302.29$302.29$286.77$287.09519.75K
Aug 19, 2026$301.04$305.93$297.62$298.38473.38K
Aug 18, 2026$301.27$303.18$297.51$298.66483.35K
Aug 17, 2026$306.93$309.78$300.79$303.18418.14K
Aug 14, 2026$310.86$314.725$306.35$307.38457K
Aug 13, 2026$301.52$313.82$299.72$312.43726.17K
Aug 12, 2026$306.22$309.0745$299.65$299.95619.88K

Latest EVR news

The latest Smart Investors Daily articles mentioning EVR.

Stock researchCompany · Overview

EVR research

Overview

Company profile and research snapshot.

Company profile

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$366.67
Implied upside
—
Analysts
14
EVR recent ratings
DateFirmRatingTarget
Aug 3, 2026BMO CapitalMarket Perform—
Jul 30, 2026Keefe, Bruyette & WoodsOutperform—
Jul 30, 2026UBSNeutral—
Jul 30, 2026Morgan StanleyEqual-Weight—
Jul 10, 2026Keefe, Bruyette & WoodsOutperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 2, 2026

Will Evercore’s (EVR) New EMEA Healthcare Hire Subtly Recast Its Advisory Edge in Europe?

Evercore recently announced that John Pissanos has joined the firm as a senior managing director in its healthcare investment banking group, based in London and focusing on life science tools, diagnostics, and medtech. His move from J.P. Morgan, where he led EMEA life science tools and diagnostics, adds specialized sector expertise that could deepen Evercore’s healthcare advisory capabilities in Europe. We’ll now examine how adding a senior EMEA healthcare banker like John Pissanos may...

Yahoo · Sep 2, 2026

Is Evercore (EVR) A Bargain On Its Healthcare Banking Hire?

How Evercore’s New Healthcare Hire Connects To The Stock Evercore (EVR) recently appointed John Pissanos as a senior managing director in its healthcare investment banking group, focusing on life science tools, diagnostics and medtech from a London base. Pissanos brings nearly 15 years of investment banking experience, most recently at J.P. Morgan as head of EMEA life science tools and diagnostics. His addition broadens Evercore’s senior coverage in a sector where specialist expertise often...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By